PCV105 - POTENTIAL REDUCTION IN MORTALITY AND HOSPITALISATIONS WITH OPTIMAL USAGE OF SACUBITRIL/VALSARTAN THERAPY FOR THE TREATMENT OF HEART FAILURE WITH REDUCED EJECTION FRACTION IN IRELAND
Oct 1, 2018, 00:00 AM
10.1016/j.jval.2018.09.650
https://www.valueinhealthjournal.com/article/S1098-3015(18)33950-0/fulltext
Section Title :
Section Order :
69
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33950-0&doi=10.1016/j.jval.2018.09.650